{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:55:04Z","timestamp":1791374104580,"version":"4.3.1"},"reference-count":19,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mirt"],"DOI":"10.4274\/mirt.galenos.2026.96630","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:31:24Z","timestamp":1791289884000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of Primary Tumor and Immune Organ Metabolic Parameters Derived from Pretreatment 18F-FDG PET\/CT in Gastric Adenocarcinoma: A Retrospective Survival Analysis"],"prefix":"10.4274","author":[{"given":"Halim","family":"\u00d6z\u00e7evik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcge \u00d6ner","family":"Tamam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve Nur Acar","family":"Tayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Sung H, Filho AM, Laversanne M, Ferlay J, Siegel RL, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin. 2026;76:e70090.","DOI":"10.3322\/caac.70090"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Acar Tayyar MN, Tamam M\u00d6, Babacan GB, \u015eahin MC, \u00d6z\u00e7evik H, \u015eengiz Erhan S, \u00d6zt\u00fcrk AE. The relationship between HER2 status acquired from pathological data and metabolic parame-ters from pre-treatment [18F]FDG PET\/CT in gastric adenocarcinomas. Rev Esp Med Nucl Imagen Mol. 2025;44:500080.","DOI":"10.1016\/j.remnie.2024.500080"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3748\/wjg.v23.i13.2385","article-title":"Clinical implication of FDG uptake of bone marrow on PET\/CT in gastric cancer patients with surgical resection","volume":"23","author":"Lee","year":"2017","unstructured":"3. Lee JW, Lee MS, Chung IK, Son MW, Cho YS, Lee SM. Clinical implication of FDG uptake of bone marrow on PET\/CT in gastric cancer patients with surgical resection. World J Gastroenterol. 2017;23:2385-2395.","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40644-020-00313-2","article-title":"18F-FDG PET\/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma","volume":"20","author":"Wong","year":"2020","unstructured":"4. Wong A, Callahan J, Keyaerts M, Neyns B, Mangana J, Aberle S, Herschtal A, Fullerton S, Milne D, Iravani A, McArthur GA, Hicks RJ. 18F-FDG PET\/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma. Cancer Imaging. 2020;20:36.","journal-title":"Cancer Imaging"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13550-020-00660-y","article-title":"[18F]FDG uptake of bone marrow on PET\/CT for predicting distant recurrence in breast cancer patients after surgical resection","volume":"10","author":"Lee","year":"2020","unstructured":"5. Lee JW, Kim SY, Han SW, Lee JE, Lee HJ, Heo NH, Lee SM. [18F]FDG uptake of bone marrow on PET\/CT for predicting distant recurrence in breast cancer patients after surgical resection. EJNMMI Res. 2020;10:72.","journal-title":"EJNMMI Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1038\/s41598-021-91608-2","article-title":"Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer","volume":"11","author":"Lee","year":"2021","unstructured":"6. Lee JH, Lee HS, Kim S, Park EJ, Baik SH, Jeon TJ, Lee KY, Ryu YH, Kang J. Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer. Sci Rep. 2021;11:12137.","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/jcm15020798","article-title":"Prognostic value of 18F-FDG PET\/CT-derived secondary lymphoid organ ratios and hematologic inflammation markers in advanced non-small cell lung cancer treated with nivolumab","volume":"15","author":"Kocaaslan","year":"2026","unstructured":"7. Kocaaslan E, G\u00fcren AK, Akag\u00fcnd\u00fcz F, Demirel A, Tun\u00e7 MA, Pa\u00e7ac\u0131 B, A\u011fyol Y, Erel P, \u00c7elebi A, I\u015f\u0131k S, \u00c7oban E, Demircan NC, \u00d6zg\u00fcven S, Balaban Gen\u00e7 ZC, Majidova N, Sever N, Sar\u0131 M, K\u00f6stek O, Bayo\u011flu IV. Prognostic value of 18F-FDG PET\/CT-derived secondary lymphoid organ ratios and hematologic inflammation markers in advanced non-small cell lung cancer treated with nivolumab. J Clin Med. 2026;15:798.","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1004351","DOI":"10.3389\/fimmu.2022.1004351","article-title":"Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancer","volume":"13","author":"Jin","year":"2022","unstructured":"8. Jin P, Bai M, Liu J, Yu J, Meng X. Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancer. Front Immunol. 2022;13:1004351.","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.21037\/qims-24-180","article-title":"Prognostic significance of diffuse increased fluorine-18-fluorodeoxyglucose uptake within the reticuloendothelial system in lym-phoma patients","volume":"14","author":"Zhao","year":"2024","unstructured":"9. Zhao Z, Zhou Y, Yao X, Ge S, Sang S, Yang Y, Zhang B, Deng S. Prognostic significance of diffuse increased fluorine-18-fluorodeoxyglucose uptake within the reticuloendothelial system in lym-phoma patients. Quant Imaging Med Surg. 2024;14:6374-6385.","journal-title":"Quant Imaging Med Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12885-026-15568-4","article-title":"Prognostic value of diffusely increased FDG uptake in spleen and\/or bone marrow due to reticuloendothelial system activation in lymphoma patients","volume":"26","author":"Song","year":"2026","unstructured":"10. Song Y, Sun J, Jiang J, Xu N, Zhao Q. Prognostic value of diffusely increased FDG uptake in spleen and\/or bone marrow due to reticuloendothelial system activation in lymphoma patients. BMC Cancer. 2026;26:233.","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Li Y, Wang X, Li Y, Li W, Liu D, Guo L, Liu X, Li Z, Liu A, Li M. The combined prognostic value of 18F-FDG PET\/CT metabolic parameters of immune organs and hematological immune-related markers in patients with locally advanced cervical cancer. Cancer Med. 2025;14:e70650.","DOI":"10.1002\/cam4.70650"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1007\/s00259-021-05322-2","article-title":"Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET\/CT as inde-pendent prognostic biomarkers of recurrence in resected breast cancer","volume":"48","author":"Seban","year":"2021","unstructured":"12. Seban RD, Rouzier R, Latouche A, Deleval N, Guinebretiere JM, Buvat I, Bidard FC, Champion L. Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET\/CT as inde-pendent prognostic biomarkers of recurrence in resected breast cancer. Eur J Nucl Med Mol Im-aging. 2021;48:3560-3570.","journal-title":"Eur J Nucl Med Mol Im-aging"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/life13030771","article-title":"Relationship of FDG uptake of the reticuloendothelial system with tumor immune microenvironment and prognosis in patients with gastric cancer","volume":"13","author":"Ahn","year":"2023","unstructured":"13. Ahn H, Song GJ, Lee MS, Lee JH, Jang SH, Oh MH, Yun JH, Lee SM, Lee JW. Relationship of FDG uptake of the reticuloendothelial system with tumor immune microenvironment and prognosis in patients with gastric cancer. Life (Basel). 2023;13:771.","journal-title":"Life (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Yoon HJ, Kim BS, Moon CM, Yoo J, Lee KE, Kim Y. Prognostic value of diffuse splenic FDG up-take on PET\/CT in patients with gastric cancer. PLoS One. 2018;13:e0196110.","DOI":"10.1371\/journal.pone.0196110"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Abdel-Dayem H M, Rosen G, El-Zeftawy H, Naddaf S, Kumar M, Atay S, Cacavio A. Fluorine-18 fluorodeoxyglucose splenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation Clin Nucl Med1999;24:319-322.","DOI":"10.1097\/00003072-199905000-00004"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Shimura, K, Mabuchi, S, Komura, N, Yokoi, E, Kozasa, K, Sasano, T, Kawano, M, Matsumoto, Y., Watabe, T, Kodama, M., Hashimoto, K., Sawada, K, Hatazawa, J, & Kimura, T. Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer. Sci Rep. 2021 26;11:2257.","DOI":"10.1038\/s41598-021-81298-1"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","unstructured":"17. Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21:345-359.","journal-title":"Nat Rev Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41591-020-0892-6","article-title":"Systemic dysfunction and plasticity of the immune macroenvironment in cancer models","volume":"26","author":"Allen","year":"2020","unstructured":"18. Allen BM, Hiam KJ, Burnett CE, Venida A, DeBarge R, Tenvooren I, Marquez DM, Cho NW, Carmi Y, Spitzer MH. Systemic dysfunction and plasticity of the immune macroenvironment in cancer models. Nat Med. 2020;26:1125-1134.","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"0","volume":"42","author":"Boellaard","year":"2015","unstructured":"19. Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328-354.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Molecular Imaging and Radionuclide Therapy"],"original-title":[],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:23:55Z","timestamp":1791372235000},"score":1,"resource":{"primary":{"URL":"https:\/\/mirt.tsnmjournals.org\/articles\/prognostic-value-of-primary-tumor-and-immune-organ-metabolic-parameters-derived-from-pretreatment-lesssupgreater18lesssupgreaterf-fdg-petct-in-gastric-adenocarcinoma-a-retrospective-survival-analysis\/doi\/mirt.galenos.2026.96630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":19,"URL":"https:\/\/doi.org\/10.4274\/mirt.galenos.2026.96630","relation":{},"ISSN":["2146-1414","2147-1959"],"issn-type":[{"value":"2146-1414","type":"print"},{"value":"2147-1959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]}}}